TY - JOUR
T1 - Impaired control of epstein-Barr virus infection in B-cell expansion with NF-κB and T-cell anergy disease
AU - Arjunaraja, Swadhinya
AU - Angelus, Pamela
AU - Su, Helen C.
AU - Snow, Andrew L.
N1 - Publisher Copyright:
© 2018 Arjunaraja, Angelus, Su and Snow.
PY - 2018/2/8
Y1 - 2018/2/8
N2 - B-cell expansion with NF-κB and T-cell anergy (BENTA) disease is a B-cell-specific lymphoproliferative disorder caused by germline gain-of-function mutations in CARD11. These mutations force the CARD11 scaffold into an open conformation capable of stimulating constitutive NF-κB activation in lymphocytes, without requiring antigen receptor engagement. Many BENTA patients also suffer from recurrent infections, with 7 out of 16 patients exhibiting chronic, low-grade Epstein-Barr virus (EBV) viremia. In this mini-review, we discuss EBV infection in the pathogenesis and clinical management of BENTA disease, and speculate on mechanisms that could explain inadequate control of viral infection in BENTA patients.
AB - B-cell expansion with NF-κB and T-cell anergy (BENTA) disease is a B-cell-specific lymphoproliferative disorder caused by germline gain-of-function mutations in CARD11. These mutations force the CARD11 scaffold into an open conformation capable of stimulating constitutive NF-κB activation in lymphocytes, without requiring antigen receptor engagement. Many BENTA patients also suffer from recurrent infections, with 7 out of 16 patients exhibiting chronic, low-grade Epstein-Barr virus (EBV) viremia. In this mini-review, we discuss EBV infection in the pathogenesis and clinical management of BENTA disease, and speculate on mechanisms that could explain inadequate control of viral infection in BENTA patients.
KW - B-cell expansion with NF-κB and T-cell anergy
KW - CARD11
KW - Epstein-Barr virus
KW - NF-κB
KW - Primary immune deficiency
UR - http://www.scopus.com/inward/record.url?scp=85041831882&partnerID=8YFLogxK
U2 - 10.3389/fimmu.2018.00198
DO - 10.3389/fimmu.2018.00198
M3 - Short survey
AN - SCOPUS:85041831882
SN - 1664-3224
VL - 9
JO - Frontiers in Immunology
JF - Frontiers in Immunology
IS - FEB
M1 - 198
ER -